# Compare Two Different Sclerosing Agents in the Treatment of Venous Malformations

> **NCT01347294** · PHASE4 · UNKNOWN · sponsor: **Oslo University Hospital** · enrollment: 135 (actual)

## Conditions studied

- Venous Malformation

## Interventions

- **DRUG:** Bleomycin
- **DRUG:** Fibrovein
- **DRUG:** Bleomycin + Fibrovein

## Key facts

- **NCT ID:** NCT01347294
- **Lead sponsor:** Oslo University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2011-08
- **Primary completion:** 2023-11-30
- **Final completion:** 2025-06-30
- **Target enrollment:** 135 (ACTUAL)
- **Last updated:** 2023-11-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01347294

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01347294, "Compare Two Different Sclerosing Agents in the Treatment of Venous Malformations". Retrieved via AI Analytics 2026-06-07 from https://api.ai-analytics.org/clinical/NCT01347294. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*